Recombinant von Willebrand factor (rVWF)
071001
Phase 3 mab completed
Quick answer
Recombinant von Willebrand factor (rVWF) for Von Willebrand Disease is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Von Willebrand Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- completed